MAPKAPK2 and COVID-19: This result was related to the increased levels of MDA adducts with kinases (cAMP-dependent protein kinase (P22612), ribose-phosphate pyrophosphokinase 3 (P21108), and MAP kinase-activated protein kinase 2 (P49137)), which were mainly observed in COVID-19 surviving patients.